News – Page 118 – Endpoints News

Pfizer partners with Flagship genetics startup Quotient on heart and kidney drugs

9 months ago

Ipsen files another Onivyde lawsuit two weeks after receiving new patent

9 months ago

Biopharma companies, BARDA call for more clarity on FDA's new platform tech proposal

9 months ago

Widening GLP-1 coverage could cost Medicare almost $150B annually, study finds

9 months ago

Eli Lilly releases single-dose vials of Zepbound at half the price of other obesity meds

9 months ago

AstraZeneca pours $135M into boosting biologics capacity in Sweden

9 months ago

Duality Biologics, an ADC partner of BeiGene and BioNTech, files for Hong Kong IPO

9 months ago

Once-promising cancer drugs appear to protect mice from Alzheimer’s

9 months ago

Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug

9 months ago

Former Regenxbio leaders take rare disease gene therapies to startup with $15M

9 months ago

Invivyd says new Phase 3 data on Covid antibody support prophylactic use

9 months ago

Illumina wins FDA approval for test to identify treatable cancers

9 months ago

Elektrofi, a startup that helps drugmakers formulate biologics for easier delivery, is raising a $112M Series C

9 months ago

RA Capital and Forbion set up new autoimmune biotech with bispecific from Korean startup

9 months ago

Updated: Oculis closes Phase 3 eye drop trial due to 'administrative error' from third party

9 months ago

Pfizer unveils direct-to-consumer push for Covid, flu and migraine treatments

9 months ago

Swiss biotech's inhibitor of cancer driver shows promise in rare bleeding disorder

9 months ago

Federal agency opposes J&J's new 340B discount model, promises to take 'actions as warranted'

9 months ago

Novartis to sell molecular imaging business to Siemens Healthineers

9 months ago

Another major PBM will cut AbbVie's Humira from its largest commercial formularies

9 months ago

Regeneron wins EU approval for lymphoma bispecific following FDA rejection

9 months ago

Once one of immuno-oncology's next great hopes, CD47 faces final shots on goal

9 months ago

Mpox vaccine collab; $11M oncology seed; Gates backs RSV vaccine; Kyowa Kirin slims portfolio

9 months ago

Major Galapagos investor says it will push board on company's 'performance' and 'strategic opportunities'

9 months ago

First page Previous page 115 116 117118119 120 121 Next page Last page